Literature DB >> 20214172

Keratoacanthomas: overview and comparison between Houston and minneapolis experiences.

Irene J Vergilis-Kalner1, Yana Kriseman, Leonard H Goldberg.   

Abstract

Keratoacanthomas represent approximately 1% of skin malignancies treated in a Mohs practice in Houston, TX. The authors compared the age of onset, sex, location and month of prevalence of keratoacanthomas between Houston, TX and Minneapolis, MN. An earlier age of presentation was observed in men in Houston (65.9 years) versus in women (71.3 years) or in men and women in Minneapolis (71 years). There was a predominance of facial tumors in Texas males compared to females and tumors seen in Minneapolis. The tumors occurred more frequently during the winter months in Houston, TX versus June, November and December in Minneapolis, MN.

Entities:  

Mesh:

Year:  2010        PMID: 20214172

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

1.  Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.

Authors:  Magdalena Claeson; Nirmala Pandeya; Jean-Claude Dusingize; Bridie S Thompson; Adele C Green; Rachel E Neale; Catherine M Olsen; David C Whiteman
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

2.  Patient and Tumour Characteristics of Keratoacanthoma in a Large, Community-based Cohort Study from Queensland, Australia.

Authors:  Agnes Kolmodin; Nirmala P Pandeya; Catherine M Olsen; Jean Claude Dusingize; David C Whiteman; Magdalena Claeson
Journal:  Acta Derm Venereol       Date:  2021-06-02       Impact factor: 3.875

3.  Successful Treatment of Generalized Eruptive Keratoacanthoma of Grzybowski with Acitretin.

Authors:  Hélène Mascitti; Adèle De Masson; Florence Brunet-Possenti; Jean-David Bouaziz; Pauline Laly; Nadim Mourad; Jean-Michel Garrigues; Sara Laurent-Roussel; Bénédicte Cavelier-Balloy; Isabelle Moulonguet; Cristina Leschi; Samia Mourah; Martine Bagot; Céleste Lebbé; Nicole Basset-Seguin
Journal:  Dermatol Ther (Heidelb)       Date:  2019-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.